2018
APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality
Satizabal CL, Samieri C, Davis-Plourde KL, Voetsch B, Aparicio HJ, Pase MP, Romero JR, Helmer C, Vasan RS, Kase CS, Debette S, Beiser AS, Seshadri S. APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality. Stroke 2018, 49: 2822-2829. PMID: 30571417, PMCID: PMC6310220, DOI: 10.1161/strokeaha.118.022132.Peer-Reviewed Original ResearchConceptsCoronary heart diseaseAPOE ε4 carriersRisk of strokeHeart diseaseSD unit increaseCause strokeIschemic strokeCause mortality eventsPlasma fatty acidsFatty acidsAPOE ε4 genotypeRandom-effects modelFatty acid levelsUnit increaseMeta-analysis resultsMetabolism of lipidsLinoleic acidCause mortalityMean agePotential confoundersCardiovascular healthRisk factorsAPOE genotypeCardiovascular diseaseDietary fat
2017
Overweight, Obesity, and Survival After Stroke in the Framingham Heart Study
Aparicio HJ, Himali JJ, Beiser AS, Davis‐Plourde K, Vasan RS, Kase CS, Wolf PA, Seshadri S. Overweight, Obesity, and Survival After Stroke in the Framingham Heart Study. Journal Of The American Heart Association 2017, 6: e004721. PMID: 28647687, PMCID: PMC5669145, DOI: 10.1161/jaha.116.004721.Peer-Reviewed Original ResearchConceptsIschemic strokeNormal weightStroke casesBody weightBody mass index measurementsWeight lossStable normal weightUnknown protective factorsStroke-free controlsNormal-weight participantsIschemic stroke casesCommunity-based sampleCase-control designFramingham Heart StudyCause mortalityBMI 18.5BMI categoriesHemorrhagic strokeObese participantsOverweight participantsBMI measurementsHeart StudyLower mortalityCase statusStroke